Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy.
Leuk Res
; 106: 106569, 2021 07.
Article
in En
| MEDLINE
| ID: mdl-33857746
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Virus Activation
/
Herpesvirus 3, Human
/
Arsenic Trioxide
/
Herpes Zoster
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Leuk Res
Year:
2021
Document type:
Article
Country of publication:
United kingdom